ENTX (STOCKS)
Entera Bio Ltd. Ordinary Shares
$1.120000
-0.030000 (-2.61%)
Prev close: $1.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Miranda J. Toledano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $52.92M
- Employees
- 21
- P/E (TTM)
- -4.49
- P/B (TTM)
- 3.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.07 | $-0.09 | +0.0218 | +23.75% |
|
Sep 2025 (Q3)
|
$-0.07 | $-0.09 | +0.0218 | +23.75% |
|
Jun 2025 (Q2)
|
$-0.06 | $-0.11 | +0.0522 | +46.52% |
|
Mar 2025 (Q1)
|
$0.06 | $-0.07 | +0.1314 | +184.03% |
Financial Statements
| Revenues | $42.00K |
| Benefits Costs and Expenses | $11.48M |
| Cost Of Revenue | $42.00K |
| Costs And Expenses | $11.48M |
| Gross Profit | $0.00 |
| Nonoperating Income/Loss | $90.00K |
| Operating Expenses | $11.53M |
| Selling, General, and Administrative Expenses | $398.00K |
| Research and Development | $6.00M |
| Other Operating Expenses | $5.13M |
| Operating Income/Loss | -$11.53M |
| Income/Loss From Continuing Operations After Tax | -$11.44M |
| Income/Loss From Continuing Operations Before Tax | -$11.44M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$11.44M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.44M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.44M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.25 |
| Diluted Earnings Per Share | $0.25 |
| Basic Average Shares | 46,191,067 |
| Diluted Average Shares | 46,191,067 |
| Assets | $15.99M |
| Current Assets | $15.30M |
| Prepaid Expenses | $37.00K |
| Other Current Assets | $15.26M |
| Noncurrent Assets | $695.00K |
| Fixed Assets | $134.00K |
| Other Non-current Assets | $561.00K |
| Liabilities | $2.89M |
| Current Liabilities | $2.20M |
| Accounts Payable | $448.00K |
| Other Current Liabilities | $1.76M |
| Noncurrent Liabilities | $689.00K |
| Equity | $13.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.10M |
| Liabilities And Equity | $15.99M |
| Net Cash Flow From Operating Activities | -$7.37M |
| Net Cash Flow From Operating Activities, Continuing | -$7.37M |
| Net Cash Flow From Investing Activities | -$107.00K |
| Net Cash Flow From Investing Activities, Continuing | -$107.00K |
| Net Cash Flow From Financing Activities | $13.71M |
| Net Cash Flow From Financing Activities, Continuing | $13.71M |
| Exchange Gains/Losses | -$36.00K |
| Net Cash Flow | $6.20M |
| Net Cash Flow, Continuing | $6.23M |
| Comprehensive Income/Loss | -$11.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.44M |
| Other Comprehensive Income/Loss | $0.00 |